We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
(+16%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
10.5%
Top 10 Holdings %
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.11M |
| 3 |
Nike
NKE
|
+$1.03M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$959K |
| 5 |
MON
Monsanto Co
MON
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.19M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.41M |
| 4 |
Enterprise Products Partners
EPD
|
+$1.02M |
| 5 |
Magna International
MGA
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.63% |
| 2 | Healthcare | 14.32% |
| 3 | Technology | 11.92% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
51
DELISTED
St Jude Medical
STJ
| $578K | 0.39% |
+10,500
| New | +$572K |
|
52
Masco
MAS
$15.9B
| $572K | 0.38% |
+18,200
| New | +$501K |
|
|
SAVE
53
DELISTED
Spirit Airlines, Inc.
SAVE
| $571K | 0.38% |
11,900
+4,000
| +51% | +$179K |
|
|
PF
54
DELISTED
Pinnacle Foods, Inc.
PF
| $567K | 0.38% |
12,700
+6,500
| +105% | +$280K |
|
55
Walt Disney
DIS
$170B
| $566K | 0.38% |
+5,700
| New | +$550K |
|
|
PPS
56
DELISTED
Post Properties
PPS
| $562K | 0.38% |
9,400
+4,500
| +92% | +$257K |
|
57
Centene
CNC
$32.8B
| $560K | 0.37% |
+18,200
| New | +$543K |
|
58
Darden Restaurants
DRI
$22.7B
| $557K | 0.37% |
+8,400
| New | +$532K |
|
59
Fortune Brands Innovations
FBIN
$6.14B
| $555K | 0.37% |
+11,583
| New | +$498K |
|
|
ELLI
60
DELISTED
Ellie Mae Inc
ELLI
| $553K | 0.37% |
+6,100
| New | +$456K |
|
|
PTLA
61
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $547K | 0.37% |
+26,800
| New | +$850K |
|
|
BCR
62
DELISTED
CR Bard Inc.
BCR
| $547K | 0.37% |
+2,700
| New | +$510K |
|
63
Abercrombie & Fitch
ANF
$4.23B
| $542K | 0.36% |
17,200
+6,800
| +65% | +$191K |
|
64
MSC Industrial Direct
MSM
$6.97B
| $542K | 0.36% |
+7,100
| New | +$476K |
|
65
Intuitive Surgical
ISRG
$122B
| $541K | 0.36% |
+8,100
| New | +$502K |
|
66
F5
FFIV
$23.1B
| $540K | 0.36% |
+5,100
| New | +$489K |
|
67
Hasbro
HAS
$11.5B
| $537K | 0.36% |
+6,700
| New | +$498K |
|
|
WBC
68
DELISTED
WABCO HOLDINGS INC.
WBC
| $535K | 0.36% |
+5,000
| New | +$473K |
|
|
NBL
69
DELISTED
Noble Energy, Inc.
NBL
| $534K | 0.36% |
+17,000
| New | +$520K |
|
70
ABM Industries
ABM
$2.79B
| $533K | 0.36% |
+16,500
| New | +$498K |
|
71
Golar LNG
GLNG
$5.05B
| $527K | 0.35% |
+29,300
| New | +$500K |
|
72
ServiceNow
NOW
$106B
| $526K | 0.35% |
+43,000
| New | +$544K |
|
73
Equity Lifestyle Properties
ELS
$12.8B
| $524K | 0.35% |
+14,400
| New | +$493K |
|
|
SPLS
74
DELISTED
Staples Inc
SPLS
| $523K | 0.35% |
47,400
+31,500
| +198% | +$296K |
|
75
Tapestry
TPR
$28.6B
| $521K | 0.35% |
+13,000
| New | +$471K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.
- Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
- Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
- Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
- Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
- Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
- Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
- Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.
Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.